ARTÍCULO

Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet

Autores: Toledo Atucha, Estefanía Ainhoa; Wang, D. D.; Ruiz-Canela López, Miguel; Clish, C. B.; Razquin Burillo, Cristina; Zheng, Y. ; Guasch-Ferre, M.; Hruby, A.; Corella, D.; Gómez-Gracia, E.; Fiol, M.; Estruch, R.; Ros, E.; Lapetra, J.; Fito, M.; Aros, F.; Serra-Majem, L.; Liang, L. M.; Salas-Salvadó, J.; Hu, F. B.; Martínez González, Miguel Ángel
Título de la revista: AMERICAN JOURNAL OF CLINICAL NUTRITION
ISSN: 0002-9165
Volumen: 106
Número: 4
Páginas: 973 - 983
Fecha de publicación: 2017
Lugar: WOS
Resumen:
Background: Lipid metabolites may partially explain the inverse association between the Mediterranean diet (MedDiet) and cardiovascular disease (CVD). Objective: We evaluated the associations between 1) lipid species and the risk of CVD (myocardial infarction, stroke, or cardiovascular death); 2) a MedDiet intervention [supplemented with extra virgin olive oil (EVOO) or nuts] and 1-y changes in these molecules; and 3) 1-y changes in lipid species and subsequent CVD. Design: With the use of a case-cohort design, we profiled 202 lipid species at baseline and after 1 y of intervention in the PREDIMED (PREvencion con DIeta MEDiterranea) trial in 983 participants [230 cases and a random subcohort of 790 participants (37 overlapping cases)]. Results: Baseline concentrations of cholesterol esters (CEs) were inversely associated with CVD. A shorter chain length and higher saturation of some lipids were directly associated with CVD. After adjusting for multiple testing, direct associations remained significant for 20 lipids, and inverse associations remained significant for 6 lipids. When lipid species were weighted by the number of carbon atoms and double bonds, the strongest inverse association was found for CEs [HR: 0.39 (95% CI: 0.22, 0.68)] between extreme quintiles (P-trend = 0.002). Participants in the MedDiet + EVOO and MedDiet + nut groups experienced significant (P < 0.05) 1-y changes in 20 and 17 lipids, respectively, compared with the control group. Of these changes, only those in CE(20:3) in the MedDiet + nuts group remained significant after correcting for multiple testing. None of the 1-y changes was significantly associated with CVD risk after correcting for multiple comparisons. Conclusions: Although the MedDiet interventions induced some significant 1-y changes in the lipidome, they were not significantly associated with subsequent CVD risk. Lipid metabolites with a longer acyl chain and higher number of double bonds at baseline were significantly and inversely associated with the risk of CVD.